Abeona Therapeutics Inc. (ABEO) Earnings History
Annual and quarterly earnings data from 1995 to 2025
Loading earnings history...
ABEO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ABEO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 73.7% | -1536.9% | 1223.1% |
| 2024 | - | - | - |
| 2023 | 54.1% | -1346.7% | -1548.2% |
| 2022 | 68.2% | -3600.8% | -2807.4% |
| 2021 | 100.0% | -2994.5% | -2831.2% |
Download Data
Export ABEO earnings history in CSV or JSON format
Free sign-in required to download data
Abeona Therapeutics Inc. (ABEO) Earnings Overview
As of May 8, 2026, Abeona Therapeutics Inc. (ABEO) reported trailing twelve-month net income of $71M, reflecting +165.2% year-over-year growth. The company earned $1.08 per diluted share over the past four quarters, with a net profit margin of 1223.1%.
Looking at the long-term picture, ABEO's historical earnings data spans multiple years. The company achieved its highest annual net income of $71M in fiscal 2025, representing a new all-time high.
Abeona Therapeutics Inc. maintains industry-leading profitability with a gross margin of 73.7%, operating margin of -1536.9%, and net margin of 1223.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including KRYS ($225M net income, 52.6% margin), RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ABEO has outperformed on profitability metrics. Compare ABEO vs KRYS →
ABEO Earnings vs Peers
Earnings metrics vs comparable public companies
ABEO Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $71M | +211.7% | -$89M | $1.01 | 1223.1% | -1536.9% |
| 2024 | -$64M | -17.6% | -$64M | $-1.55 | - | - |
| 2023 | -$54M | -36.5% | -$47M | $-2.53 | -1548.2% | -1346.7% |
| 2022 | -$40M | +53.3% | -$51M | $-5.53 | -2807.4% | -3600.8% |
| 2021 | -$85M | -0.8% | -$90M | $-21.50 | -2831.2% | -2994.5% |
| 2020 | -$84M | -10.4% | -$81M | $-22.75 | -842.3% | -814.2% |
| 2019 | -$76M | -34.6% | -$77M | $-38.07 | - | - |
| 2018 | -$57M | -107.4% | -$58M | $-29.81 | -1890.3% | -1940.2% |
| 2017 | -$27M | -24.9% | -$28M | $-16.40 | -3263.9% | -3325.7% |
| 2016 | -$22M | -50.6% | -$24M | $-16.00 | -2460.4% | -2686.3% |
See ABEO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABEO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABEO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABEO — Frequently Asked Questions
Quick answers to the most common questions about buying ABEO stock.
Is ABEO growing earnings?
ABEO EPS is $1.08, with earnings growth accelerating to +165.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $71M.
What are ABEO's profit margins?
Abeona Therapeutics Inc. net margin is +1223.1%, with operating margin at -1536.9%. Above-average margins indicate pricing power.
How consistent are ABEO's earnings?
ABEO earnings data spans 1995-2025. The accelerating earnings trend is +165.2% YoY. Historical data enables comparison across business cycles.